Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
While they act via identical mechanisms, AOD9604 is often preferred in oral administration studies due to its resistance to digestive enzymes, whereas standard 176-191 requires parenteral administration in research settings
The standard GLOW protocol ratio is 5:1:1 for GHK-Cu:TB-500:BPC-157 by weight, reflecting GHK-Cus lower potency requiring higher doses to achieve comparable tissue effects
order: 1000 pieces 2 sold Guangzhou Chamer Cosmetics Co., Ltd 5 yrsCN5.0/5.0 11% Reorder rate 17 Interested customers Market Trends of GHK-Cu and AHK-Cu Difference The global market for copper peptides like GHK-Cu and AHK-Cu is experiencing robust growth, driven by increasing demand in cosmetic, pharmaceutical, and nutraceutical industries
Many individuals share their success stories, emphasizing the product's role in improving their quality of life
BENEFITS Tissue repair studied for accelerating recovery in tendon, ligament, and muscle models Gut protection explored for protective effects on gastric and intestinal lining Angiogenesis linked to promotion of new blood vessel formation in healing tissues Anti-inflammatory associated with reduction of inflammatory markers in preclinical research Neuroprotection investigated for potential nerve regeneration pathways WHAT RESEARCHERS LOOK AT Angiogenesis and vascularization in connective tissue recovery Fibroblast migration and collagen deposition pathways Gastric and intestinal lining protection in animal models Neuroprotective and anti-inflammatory signaling cascades Synergistic effects when combined with TB-500 (Thymosin Beta-4)
